- call +1-201-465-4211
- email sales@mrinsights.biz
Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
Scope of the Report:
Traveler’s diarrhea is the leading cause of illness among international travelers to developing countries. Enterotoxigenic Escherichia coli (ETEC) bacteria are the primary cause of this disease. Among the estimated 65 million travelers from industrialized countries to high-risk areas in the developing world, as many as 50% may experience at least one TD episode during their journey. ETEC is usually responsible for 22-60% of all TD cases in both civilian and military groups or about 7-18 million cases per year. ETEC is also a major cause of diarrheal disease in children living in countries endemic for ETEC, leading to over 400 million diarrheal episodes and approximately 300,000 deaths each year.
The classification of Traveler’s Diarrhea Therapeutics includes Immunization, Non-antibiotic Agents, Antibiotics, Anti-Motility Agents, Other. And the proportion of Non-antibiotic Agents in 2017 is about 36%, and And the proportion of Anti-Motility Agents in 2017 is about 20%.
The worldwide market for Traveler's Diarrhea Therapeutics is expected to grow at a CAGR of roughly 7.1% over the next five years, will reach 890 million US$ in 2024, from 630 million US$ in 2019, according to a new study.
This report focuses on the Traveler's Diarrhea Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Other
Market Segment by Applications, can be divided into
Adult Traveler's Diarrhea
Children Traveler's Diarrhea
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Traveler's Diarrhea Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Traveler's Diarrhea Therapeutics, with price, sales, revenue and global market share of Traveler's Diarrhea Therapeutics in 2017 and 2018.
Chapter 3, the Traveler's Diarrhea Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Traveler's Diarrhea Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Traveler's Diarrhea Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Traveler's Diarrhea Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Traveler's Diarrhea Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Immunization
1.2.2 Non-antibiotic Agents
1.2.3 Antibiotics
1.2.4 Anti-Motility Agents
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 Adult Traveler's Diarrhea
1.3.2 Children Traveler's Diarrhea
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Salix Pharmaceuticals
2.1.1 Business Overview
2.1.2 Traveler's Diarrhea Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 P&G
2.2.1 Business Overview
2.2.2 Traveler's Diarrhea Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 P&G Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Traveler's Diarrhea Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Otsuka Pharma
2.4.1 Business Overview
2.4.2 Traveler's Diarrhea Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Valneva
2.5.1 Business Overview
2.5.2 Traveler's Diarrhea Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Valneva Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Shanghai United Cell
2.6.1 Business Overview
2.6.2 Traveler's Diarrhea Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 PaxVax
2.7.1 Business Overview
2.7.2 Traveler's Diarrhea Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 PaxVax Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Livzon
2.8.1 Business Overview
2.8.2 Traveler's Diarrhea Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Livzon Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Immuron
2.9.1 Business Overview
2.9.2 Traveler's Diarrhea Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Immuron Traveler's Diarrhea Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Traveler's Diarrhea Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Traveler's Diarrhea Therapeutics Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Traveler's Diarrhea Therapeutics Manufacturer Market Share in 2018
3.3.2 Top 6 Traveler's Diarrhea Therapeutics Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Traveler's Diarrhea Therapeutics Market Analysis by Regions
4.1 Global Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Traveler's Diarrhea Therapeutics Sales and Market Share by Regions (2014-2019)
4.1.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Regions (2014-2019)
4.2 North America Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
4.3 Europe Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
4.5 South America Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
5 North America Traveler's Diarrhea Therapeutics by Country
5.1 North America Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America Traveler's Diarrhea Therapeutics Sales and Market Share by Country (2014-2019)
5.1.2 North America Traveler's Diarrhea Therapeutics Revenue and Market Share by Country (2014-2019)
5.2 United States Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
5.3 Canada Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
5.4 Mexico Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
6 Europe Traveler's Diarrhea Therapeutics by Country
6.1 Europe Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Country
6.1.1 Europe Traveler's Diarrhea Therapeutics Sales and Market Share by Country (2014-2019)
6.1.2 Europe Traveler's Diarrhea Therapeutics Revenue and Market Share by Country (2014-2019)
6.2 Germany Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
6.3 UK Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
6.4 France Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
6.5 Russia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
6.6 Italy Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
7 Asia-Pacific Traveler's Diarrhea Therapeutics by Country
7.1 Asia-Pacific Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Traveler's Diarrhea Therapeutics Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Traveler's Diarrhea Therapeutics Revenue and Market Share by Country (2014-2019)
7.2 China Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
7.3 Japan Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
7.4 Korea Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
7.5 India Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
8 South America Traveler's Diarrhea Therapeutics by Country
8.1 South America Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Country
8.1.1 South America Traveler's Diarrhea Therapeutics Sales and Market Share by Country (2014-2019)
8.1.2 South America Traveler's Diarrhea Therapeutics Revenue and Market Share by Country (2014-2019)
8.2 Brazil Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
8.3 Argentina Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
8.4 Colombia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
9 Middle East and Africa Traveler's Diarrhea Therapeutics by Countries
9.1 Middle East and Africa Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Traveler's Diarrhea Therapeutics Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Traveler's Diarrhea Therapeutics Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
9.3 Turkey Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
9.4 Egypt Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
9.5 Nigeria Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
9.6 South Africa Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
10 Global Traveler's Diarrhea Therapeutics Market Segment by Type
10.1 Global Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Traveler's Diarrhea Therapeutics Sales and Market Share by Type (2014-2019)
10.1.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Immunization Sales Growth and Price
10.2.1 Global Immunization Sales Growth (2014-2019)
10.2.2 Global Immunization Price (2014-2019)
10.3 Non-antibiotic Agents Sales Growth and Price
10.3.1 Global Non-antibiotic Agents Sales Growth (2014-2019)
10.3.2 Global Non-antibiotic Agents Price (2014-2019)
10.4 Antibiotics Sales Growth and Price
10.4.1 Global Antibiotics Sales Growth (2014-2019)
10.4.2 Global Antibiotics Price (2014-2019)
10.5 Anti-Motility Agents Sales Growth and Price
10.5.1 Global Anti-Motility Agents Sales Growth (2014-2019)
10.5.2 Global Anti-Motility Agents Price (2014-2019)
10.6 Other Sales Growth and Price
10.6.1 Global Other Sales Growth (2014-2019)
10.6.2 Global Other Price (2014-2019)
11 Global Traveler's Diarrhea Therapeutics Market Segment by Application
11.1 Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2014-2019)
11.2 Adult Traveler's Diarrhea Sales Growth (2014-2019)
11.3 Children Traveler's Diarrhea Sales Growth (2014-2019)
12 Traveler's Diarrhea Therapeutics Market Forecast (2019-2024)
12.1 Global Traveler's Diarrhea Therapeutics Sales, Revenue and Growth Rate (2019-2024)
12.2 Traveler's Diarrhea Therapeutics Market Forecast by Regions (2019-2024)
12.2.1 North America Traveler's Diarrhea Therapeutics Market Forecast (2019-2024)
12.2.2 Europe Traveler's Diarrhea Therapeutics Market Forecast (2019-2024)
12.2.3 Asia-Pacific Traveler's Diarrhea Therapeutics Market Forecast (2019-2024)
12.2.4 South America Traveler's Diarrhea Therapeutics Market Forecast (2019-2024)
12.2.5 Middle East and Africa Traveler's Diarrhea Therapeutics Market Forecast (2019-2024)
12.3 Traveler's Diarrhea Therapeutics Market Forecast by Type (2019-2024)
12.3.1 Global Traveler's Diarrhea Therapeutics Sales Forecast by Type (2019-2024)
12.3.2 Global Traveler's Diarrhea Therapeutics Market Share Forecast by Type (2019-2024)
12.4 Traveler's Diarrhea Therapeutics Market Forecast by Application (2019-2024)
12.4.1 Global Traveler's Diarrhea Therapeutics Sales Forecast by Application (2019-2024)
12.4.2 Global Traveler's Diarrhea Therapeutics Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Traveler's Diarrhea Therapeutics Picture
Table Product Specifications of Traveler's Diarrhea Therapeutics
Figure Global Sales Market Share of Traveler's Diarrhea The
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
